A research team led by Swiss developmental biologist Dieter Egli at Columbia University has successfully performed precise genome editing in viable human embryos using base editing technology. This development has reignited debates around the potential and risks of genetic modifications in human embryos. The study was reported by the New York Times and highlights advancements in gene-editing techniques such as CRISPR/Cas9. Previous controversies, like those involving Chinese scientist He Jiankui in 2018, have raised ethical concerns regarding the manipulation of human embryos.
Bias read (Center): The article presents scientific developments and their implications without overtly favoring any political stance. It references past controversies and current research neutrally, focusing on the technological and ethical aspects rather than taking a clear ideological position.
